Not from Aurora Health Care? Click the title link for additional options to access full-text. For best viewing, we recommend Google Chrome.

Follow

Works from 2020

Link

Phase II trial of carfilzomib plus irinotecan in patients with small-cell lung cancer who have progressed on prior platinum-based chemotherapy, Susanne M Arnold, Kari Chansky, Maria Q Baggstrom, Michael A. Thompson, Rachel E Sanborn, John L Villano, Saiama N Waqar, John Hamm, Markos Leggas, Maurice Willis, Joseph Rosales, and John J Crowley (Article)

Link

Transplant referral patterns for patients (pts) with newly diagnosed (ND) higher-risk (HR) myelodysplastic dyndromes (MDS), and European leukemianet (ELN) 2010 intermediate-tisk (IR) or adverse-risk (AR) acute myeloid leukemia (AML) in the Connect® MDS/AML registry, Benjamin Tomlinson, Marcos de Lima, Christopher R. Cogle, Michael A. Thompson, David L. Grinblatt, Daniel A. Pollyea, Rami Komrokji, Gail J. Roboz, Michael R. Savona, Mikkael A. Serkeres, E Dawn Flick, Pavel Kiselev, Chrystal U. Louis, Melissa Nifenecker, Arlene S. Swern, Harry P. Erba, David P. Steensma, and Bart L. Scott (Abstract)

Works from 2019

Determining value of a precision medicine program in a vertically integrated healthcare system, James Weese, Michael A. Thompson, and Jennifer Godden (Oral/Podium Presentation)

Link

Mo1412 – Oncologic outcomes of robotic compared to open pancreatic surgery: A national cancer database participant user file study, Geoffrey Bellini, Maharaj Singh, James Weese, Aaron H. Chevinsky, and Wesley Papenfuss (Abstract)

Link

Use of treatment pathways reduce cost and decrease ED utilization and unplanned hospital admissions in patients (pts) with stage II breast cancer, James Weese, Corey J. Shamah, Federico A. Sanchez, Ana C. Perez Moreno, Dorry Mitchell, Thomas Sessa, Jean Gutantes, Carol Huibregtse, Kevin Clement, Anne Barry-Weers, Amy Bock, and Marija Bjegovich-Weidman (Abstract)